ArticleFrontiers in veterinary science2026
Anti-inflammatory, analgesic, and anti-immune-mediated polyarthritis activities of topically applied polarity fractions of
Article in Frontiers in veterinary science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Methods: Results: Phytochemical analysis revealed that the extract is rich in saponins and flavonoids, which exhibit distinct distribution patterns across fractions of varying polarity. All fractions exhibited anti-inflammatory effects in the ear edema model and analgesic activity in the writhing test. In the arthritis model, topical application of the EA, BU, and WA fractions significantly attenuated paw swelling and reduced serum levels of TNF-α, COX-2, rheumatoid factor, and IL-6. Histological staining confirmed partial protection against joint destruction. Mechanistic studies revealed that these fractions enhanced ERK phosphorylation and suppressed NF-κB activation in joint tissues. Conclusion: The EA, BU, and WA fractions of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.